Merck KGaA Strengthens Its Biotech Presence With Serono Acquisition
Executive Summary
Merck KGaA's acquisition of Serono, Europe's leading biotechnology company, will enhance the German drug maker's position in biologics with a portfolio generating over $2 bil. in sales in the segment